PHARMARESEARCH BIO Co., Ltd. (XKON:217950)
South Korea flag South Korea · Delayed Price · Currency is KRW
34,250
-650 (-1.86%)
At close: Aug 1, 2025, 3:30 PM KST

PHARMARESEARCH BIO Company Description

PharmaResearch BIO Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products worldwide.

The company offers ReNTox injection for temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged between 18 and 65.

It is also developing Clostridium Botulinum Toxin type A, which is in Phase I clinical study for indications, including dynamic equinus foot deformity, upper limb spasticity, blepharospasm, etc. The company was formerly known as BIOCND Inc. and changed its name to PharmaResearch BIO Co., Ltd. in March 2018.

PharmaResearch BIO Co., Ltd. was founded in 2009 and is headquartered in Gangneung, South Korea.

PHARMARESEARCH BIO Co., Ltd.
CountrySouth Korea
Founded2009
IndustryPharmaceutical Preparations

Contact Details

Address:
641-3, Saimdang-ro
Gangneung
South Korea
Phone82 3 3655 7560
Websitepr-bio.co.kr

Stock Details

Ticker Symbol217950
ExchangeKorea New Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
SIC Code2834